Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

FDA Releases Guidance on Reporting Potential Disruptions in Supply During COVID-19 Pandemic

Alert

  • News and Insights
  • FDA Releases Guidance on Reporting Potential Disruptions in Supply During COVID-19 Pandemic

On Friday, March 27, 2020, the U.S. Food and Drug Administration (FDA) released updated guidance to ensure that drug manufacturers notify FDA as soon as possible of potential interruptions in manufacturing that could lead to drug shortages. The Guidance, titled “Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act,” was published for immediate implementation, in light of the importance of working with FDA on potential supply disruptions and drug shortages during the COVID-19 pandemic.

View More

Share links:

Share links:

Related Professionals

Related Practices

Related Offices

Related Regions

Related News & Insights